Concord Drugs Ltd Q2 FY2025-2026 Results: Summary
Revenue | ₹10.28Cr |
Net Profits | ₹0.19Cr |
Net Profit Margins | 1.85% |
Concord Drugs Ltd’s revenue fell -16.9% since last year same period to ₹10.28Cr in the Q2 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated -24.47% fall in its revenue since last 3-months.
Concord Drugs Ltd’s net profit jumped 375% since last year same period to ₹0.19Cr in the Q2 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 58.33% jump in its net profits since last 3-months.
Concord Drugs Ltd’s net profit margin jumped 471.57% since last year same period to 1.85% in the Q2 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 109.62% jumped in its net profit margins since last 3-months.
FAQs
What was the revenue for Concord Drugs Ltd in Q2 results 2025?
The revenue for Concord Drugs Ltd in the Q2 results 2025 was ₹10.28Cr.
What was the net profit for Concord Drugs Ltd in Q2 results 2025?
The net profit for Concord Drugs Ltd in the Q2 results 2025 was ₹0.19Cr.
What was the net profit margin for Concord Drugs Ltd in Q2 results 2025?
The net profit margin for Concord Drugs Ltd in the Q2 results 2025 was 1.85%.
What was the revenue for Concord Drugs Ltd in Q2 results 2024?
The revenue for Concord Drugs Ltd in the Q2 results 2024 was ₹12.37Cr.
What was the net profit for Concord Drugs Ltd in Q2 results 2024?
The net profit for Concord Drugs Ltd in the Q2 results 2024 was ₹0.04Cr.
What was the net profit margin for Concord Drugs Ltd in Q2 results 2024?
The net profit margin for Concord Drugs Ltd in the Q2 results 2024 was 0.32%.
